By GREGORY ZELLER // An accomplished Long Island biotech with a penchant for polymerase chain reaction-based DNA technologies has earned state approvals for a cutting-edge pharmacogenomic testing service. Pharmacogenomics, the…
By GREGORY ZELLER // A modest state investment will help push a Long Island bioscience pioneer toward the brink of a DNA-manufacturing revolution. Through its Excelsior Jobs Program and chunky…
By GREGORY ZELLER // Applied DNA Sciences is ready to play a little monkey ball. The Stony Brook-based biotech – part supply-chain authenticator, part Polymerase Chain Reaction-based DNA technology leader,…
By GREGORY ZELLER // With the novel coronavirus reestablishing its national dominance, the New York State Department of Health has wasted no time greenlighting a Long Island biotech’s next-generation COVID-detection…
By GREGORY ZELLER // It’s been a big week for one of Long Island’s boldest biotechs. Applied DNA Sciences, a Stony Brook-based leader in polymerase chain reaction-based DNA manufacturing, has…
By GREGORY ZELLER // One of Long Island’s busiest biotechs has spun off another local startup, this time focused on testing its own potential breakthroughs. Stony Brook-based Applied DNA Sciences,…